Eur Urol
June 2009
Background: Few randomised studies have compared intermittent hormonal therapy (IHT) with continuous therapy for the treatment of advanced prostate cancer (PCa).
Objective: To determine whether intermittent therapy is associated with a shorter time to progression.
Design, Setting, And Participants: 766 patients with locally advanced or metastatic PCa received a 3-mo induction treatment.